Delcath Systems Inc.

Delcath Systems, Inc. (the "Company"), today announced the sale of 5,185,000 shares of its common stock pursuant to an underwriting agreement with Canaccord Ge...

Delcath Systems, Inc. announced today that management will present at the 30th Annual Canaccord Global Growth Conference in Boston, MA on Thursday, August 12, 2010 at 8:...

Delcath Systems, Inc. announced today that it will present at the 2010 Wedbush Securities Life Sciences Best Ideas Management Access Conference in New York, NY on Tuesda...

Delcath Systems, Inc. announced today that it will host a conference call to discuss its second quarter results and recent corporate developments on Thursday, July 29, 2...

Delcath Systems, Inc. a development stage, specialty pharmaceutical and medical device company focused on oncology announced today changes to its Board of Directors. Dou...